萝莉社

萝莉社 Jacksonville has become the first hospital in Florida and the Southeast 鈥� and only the second in the United States 鈥� to use an innovative technology designed to improve outcomes for patients experiencing a life-threatening heart emergency.

On Feb. 21, , a board-certified thoracic and cardiac surgeon, used the AMDS^TM Hybrid Prosthesis, the world鈥檚 first aortic arch remodeling device for use in the treatment of acute DeBakey Type I aortic dissections, to perform an emergency operation on a patient with an aortic dissection. Aortic dissection occurs when the inner wall of the body鈥檚 largest blood vessel tears, causing severe complications such as organ failure or death.

Dr. Belli called the device a 鈥渕ajor advance鈥� for patients facing this serious medical condition.

鈥淎cute DeBakey Type I aortic dissection is a condition with a high mortality rate that requires immediate surgical repair, yet standard surgical procedures don鈥檛 always address all the issues of the diseased aorta, which can lead to future complications,鈥� Dr. Belli said. 鈥淏y incorporating this new device in the surgery, we are leading the way in improving patient survival rates and patient quality of life.鈥�

The device, developed by Artivion Inc., was approved by the U.S. Food and Drug Administration under a Humanitarian Device Exemption. The safety and efficacy of AMDS is being studied in the PERSEVERE trial and it has demonstrated a 30-day reduction in major adverse events compared with current standard of treatment, specifically mortality, new disabling stroke and new onset of renal failure requiring dialysis. Latest one-year data continues to demonstrate a low risk of death with AMDS and positive remodeling of the aortic arch, which would promote better healing of the aorta in the treatment of acute aortic dissections.